Prostate Cancer Now UK’s Most Diagnosed Cancer, Surpassing Breast Cancer

Prostate cancer is now the most frequently diagnosed cancer in the United Kingdom, according to updated figures from Macmillan Cancer Support. The organisation reports that approximately 68,000 men receive a prostate cancer diagnosis each year—equating to roughly one new case every eight minutes—surpassing the annual tally of around 59,000 new breast cancer diagnoses.

600,000 Men Living With Prostate Cancer

Macmillan’s latest estimates indicate that some 600,000 men in the UK are currently living with prostate cancer—a rise of about 100,000 since 2020, when the figure stood at approximately 500,000. This growth reflects both improved detection and longer survival rates, rather than an absolute increase in incidence, experts stress.

The shift follows heightened public awareness, including a high-profile campaign led by former Olympic champion Sir Chris Hoy, who revealed he had been diagnosed with advanced-stage prostate cancer. His disclosure drew support from charitable organisations and political figures urging more men to seek timely screening.

“Feeling Well Doesn’t Mean You’re Not Affected”

Macmillan warns that persistent misconceptions may deter men from pursuing medical evaluation. Dr Anthony Kneale, Macmillan’s chief medical adviser, highlighted one widespread myth: the belief that feeling healthy automatically rules out prostate cancer.

He explained that the disease often develops asymptomatically in its early stages and urged men to consult their GP if they experience concern or notice any worrying signs.

Earlier data collected by Cancer Research UK recorded about 58,000 new prostate cancer cases per year, slightly below the 59,000 new breast cancer cases. Macmillan’s more recent figures confirm prostate cancer has now overtaken breast cancer in terms of annual new diagnoses.

Symptoms That Warrant Medical Attention

Some men with prostate cancer may remain symptom-free for years. Symptoms typically emerge only when the tumour grows large enough to press on the urethra. Key indicators include:

• Difficulty urinating
• Frequent urination, especially at night
• A sensation that the bladder is not fully emptied
• Urgent need to urinate
• Blood in the urine
• Blood in the semen

Macmillan stresses that any of these symptoms should prompt consultation with a healthcare professional.

Dr Kneale noted that prostate cancer predominantly affects men over 50, but it can occur at younger ages among certain groups—including Black men and those with a family history of the disease.

Rising Diagnoses Do Not Necessarily Signal Rising Incidence

Specialists caution against interpreting rising case numbers as evidence of increased disease prevalence. Consultant surgeon Ben Lamb of the Barts Cancer Institute observed that the growing number of men living with prostate cancer is likely attributable primarily to earlier detection and improved survival—not a simple rise in new cancers.

He added that the trend reflects more men living for extended periods with the consequences of diagnosis and treatment, rather than a surge in biological occurrence.

Clinical researcher Dr Alistair Lamb of St Bartholomew’s Hospital stated there is no evidence whatsoever that prostate cancer itself is becoming more common. He clarified that the rise in recorded diagnoses stems from diagnostic practices—not from an actual increase in disease presence—and pointed to stable mortality rates as supporting this interpretation.

Debate Over Routine PSA Testing

Sir Chris Hoy has reignited national discussion on whether the prostate-specific antigen (PSA) blood test should be offered proactively to asymptomatic men. The six-time Olympic gold medallist advocates broader access to testing and earlier initiation of screening.

Currently, men aged 50 and over in the UK can request a PSA test through the National Health Service (NHS). If results show elevated PSA levels, patients undergo further investigations—including imaging and additional diagnostics—to determine the cause.

Why Population-Wide Screening Is Not Recommended

The UK National Screening Committee (UKNSC) advised earlier this year against implementing universal PSA blood testing for all men. It concluded that potential harms outweigh benefits.

The committee based its recommendation on population modelling indicating current blood tests lack sufficient accuracy. False positives could lead to unnecessary treatment for benign or indolent tumours unlikely to cause harm during a man’s lifetime.

Prostate cancer is known to progress extremely slowly in some individuals. Existing screening methods still struggle to reliably distinguish between aggressive, life-threatening tumours and slow-growing ones that may never require intervention.